{{cart_num}}
My CartCAS：81103-11-9
Molecular Formula：C38H69NO13
Molecular Weight：747.97
Storage：Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year
Purity：HPLC≥98%
Appearance：White to off-white Solid
Qty：
Size：
| CAS | 81103-11-9 |
| Name | Clarithromycin |
| Molecular Formula | C38H69NO13 |
| Molecular Weight | 747.97 |
| Solubility | Soluble in DMSO ≥10mg/mL |
| Purity | HPLC≥98% |
| Appearance | White to off-white Solid |
| Storage | Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year |
| EC | EINECS 1806241-263-5 |
| MDL | MFCD00865140 |
| SMILES | C[C@@](OC)(C[C@H](C([C@@H]1C)=O)C)[C@@H]([C@H]([C@@H]([C@H](C(O[C@H](CC)[C@@](C)(O)[C@@H]1O)=O)C)O[C@@](O[C@@H](C)[C@@H]2O)([H])C[C@@]2(C)OC)C)O[C@@](O[C@H](C)C[C@@H]3N(C)C)([H])[C@@H]3O |
| InChIKey | AGOYDEPGAOXOCK-KCBOHYOISA-N |
| InChI | InChI=1S/C38H69NO13/c1-15-26-38(10,45)31(42)21(4)28(40)19(2)17-37(9,47-14)33(52-35-29(41)25(39(11)12)16-20(3)48-35)22(5)30(23(6)34(44)50-26)51-27-18-36(8,46-13)32(43)24(7)49-27/h19-27,29-33,35,41-43,45H,15-18H2,1-14H3/t19-,20-,21+,22+,23-,24+,25+,26-,27+,29-,30+,31-,32+,33-,35+,36-,37-,38-/m1/s1 |
| PubChem CID | 84029 |
| Target Point | Bacterial |
| Passage | Anti-infection |
| Background | Clarithromycin has a broad spectrum of antibacterial activity. Clarithromycin has been reported to inhibit the α-hydroxylation of triazolam catalyzed by CYP3A4. Clarithromycin inhibits HERG potassium current. Clarithromycin affects autophagic flux by weakening the signaling pathway that connects hERG1 and PI3K. |
| Unit | Bottle |
| Specification | 50mg 10mM*1mL in DMSO 100mg |
Remark：These protocols are for reference only. Solarbio does not independently validate these methods.
Note：
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.
High treatment failure rate is better explained by resistance gene detection than by minimum inhibitory concentration in patients with urogenital Chlamydia trachomatis infection
Click to check >>Author：ShaoL;YouC;CaoJ;JiangY;LiuY;LiuQ
IF：2.8590
Publish_to：Int J Infect Dis
PMID：32173573
A case of multidrug-resistant Mycobacterium simiae in an elderly woman
Click to check >>Author：Lotfi H; Aryan E; Sankian M; Meshkat Z; Khalifeh S
IF：0.8000
Publish_to：Respirol Case Rep
PMID：33552522
Manual Download
